SCHEMBL13007141

SCHEMBL13007141

CCCCCCCCCCCC[C@H]1CC[C@H](N)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.48
GNAI3 P08754 2/20 0.47
GNAO1 P09471 2/20 0.47
GNAI1 P63096 2/20 0.47
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
EPHX1 P07099 1/20 0.43
SPHK1 Q9NYA1 5/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
LSS P48449 2/20 0.40
SIGMAR1 Q99720 1/20 0.40
PKM P14618 1/20 0.40
SPHK2 Q9NRA0 3/20 0.39
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2406519 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL4385726 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL2404044 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL25015819 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL2405787 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL24920262 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL2405113 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL25015820 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL2406734 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT
SCHEMBL2405816 1.00 CYP1A2 (0.48) CYP1A2GNAI3GNAO1GNAI1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740578-B1 4- 2- (CYCLOALKYLAMINO) PYRIMIDIN-4-YL ] - (PHENYL) - IMIDAZOLIN-2- ONE DERIVATIVES AS P38 MAP- KINASE INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES MITSUBISHI TANABE PHARMA CORP (JP) 2010-12-15 EP disclosed